DOJ Can't 'Salvage' Novel Insider Trading Case, Exec Says
The former healthcare CEO at the center of a novel insider trading indictment has moved to dismiss the criminal charges against him, arguing prosecutors failed to allege that shareholders were kept...To view the full article, register now.
Already a subscriber? Click here to view full article